Cargando…

Correction: Preclinical evaluation of biomarkers associated with antitumor activity of MELK inhibitor

Detalles Bibliográficos
Autores principales: Chung, Suyoun, Kijima, Kyoko, Kudo, Aiko, Fujisawa, Yoshiko, Harada, Yosuke, Taira, Akiko, Takamatsu, Naofumi, Miyamoto, Takashi, Matsuo, Yo, Nakamura, Yusuke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7566805/
https://www.ncbi.nlm.nih.gov/pubmed/33110482
http://dx.doi.org/10.18632/oncotarget.27755
_version_ 1783596200023293952
author Chung, Suyoun
Kijima, Kyoko
Kudo, Aiko
Fujisawa, Yoshiko
Harada, Yosuke
Taira, Akiko
Takamatsu, Naofumi
Miyamoto, Takashi
Matsuo, Yo
Nakamura, Yusuke
author_facet Chung, Suyoun
Kijima, Kyoko
Kudo, Aiko
Fujisawa, Yoshiko
Harada, Yosuke
Taira, Akiko
Takamatsu, Naofumi
Miyamoto, Takashi
Matsuo, Yo
Nakamura, Yusuke
author_sort Chung, Suyoun
collection PubMed
description
format Online
Article
Text
id pubmed-7566805
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Impact Journals LLC
record_format MEDLINE/PubMed
spelling pubmed-75668052020-10-26 Correction: Preclinical evaluation of biomarkers associated with antitumor activity of MELK inhibitor Chung, Suyoun Kijima, Kyoko Kudo, Aiko Fujisawa, Yoshiko Harada, Yosuke Taira, Akiko Takamatsu, Naofumi Miyamoto, Takashi Matsuo, Yo Nakamura, Yusuke Oncotarget Correction Impact Journals LLC 2020-10-13 /pmc/articles/PMC7566805/ /pubmed/33110482 http://dx.doi.org/10.18632/oncotarget.27755 Text en https://creativecommons.org/licenses/by/3.0/ Copyright: © 2020 Chung et al. This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Correction
Chung, Suyoun
Kijima, Kyoko
Kudo, Aiko
Fujisawa, Yoshiko
Harada, Yosuke
Taira, Akiko
Takamatsu, Naofumi
Miyamoto, Takashi
Matsuo, Yo
Nakamura, Yusuke
Correction: Preclinical evaluation of biomarkers associated with antitumor activity of MELK inhibitor
title Correction: Preclinical evaluation of biomarkers associated with antitumor activity of MELK inhibitor
title_full Correction: Preclinical evaluation of biomarkers associated with antitumor activity of MELK inhibitor
title_fullStr Correction: Preclinical evaluation of biomarkers associated with antitumor activity of MELK inhibitor
title_full_unstemmed Correction: Preclinical evaluation of biomarkers associated with antitumor activity of MELK inhibitor
title_short Correction: Preclinical evaluation of biomarkers associated with antitumor activity of MELK inhibitor
title_sort correction: preclinical evaluation of biomarkers associated with antitumor activity of melk inhibitor
topic Correction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7566805/
https://www.ncbi.nlm.nih.gov/pubmed/33110482
http://dx.doi.org/10.18632/oncotarget.27755
work_keys_str_mv AT chungsuyoun correctionpreclinicalevaluationofbiomarkersassociatedwithantitumoractivityofmelkinhibitor
AT kijimakyoko correctionpreclinicalevaluationofbiomarkersassociatedwithantitumoractivityofmelkinhibitor
AT kudoaiko correctionpreclinicalevaluationofbiomarkersassociatedwithantitumoractivityofmelkinhibitor
AT fujisawayoshiko correctionpreclinicalevaluationofbiomarkersassociatedwithantitumoractivityofmelkinhibitor
AT haradayosuke correctionpreclinicalevaluationofbiomarkersassociatedwithantitumoractivityofmelkinhibitor
AT tairaakiko correctionpreclinicalevaluationofbiomarkersassociatedwithantitumoractivityofmelkinhibitor
AT takamatsunaofumi correctionpreclinicalevaluationofbiomarkersassociatedwithantitumoractivityofmelkinhibitor
AT miyamototakashi correctionpreclinicalevaluationofbiomarkersassociatedwithantitumoractivityofmelkinhibitor
AT matsuoyo correctionpreclinicalevaluationofbiomarkersassociatedwithantitumoractivityofmelkinhibitor
AT nakamurayusuke correctionpreclinicalevaluationofbiomarkersassociatedwithantitumoractivityofmelkinhibitor